학술논문

A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single-Dose and Multiple-Rising-Dose Study of the BTK Inhibitor TAK-020 in Healthy Subjects
Document Type
Article
Source
In: Clinical and Translational Science. (Clinical and Translational Science, May 2021, 14(3):820-828)
Subject
Language
English
ISSN
17528062
17528054